Primenenie BETA-adrenoblokatorov pri serdechno-sosudistykh zabolevaniyakh: sovremennye rekomendatsii
- Authors: Yavelov I.S1
-
Affiliations:
- Городская клиническая больница №29, Москва
- Issue: Vol 7, No 11 (2005)
- Pages: 945-956
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/92054
- ID: 92054
Cite item
Full Text
Abstract
В 2004 г. опубликовано соглашение экспертов Европейского кардиологического общества (ЕКО), касающееся применения b-адреноблокаторов (ББ) у больных с сердечно-сосудистыми заболеваниями [1]. В его основу положены тщательный анализ опубликованных фактов, а также данные рекомендаций по лечению различных сердечно-сосудистых заболеваний, подготовленных Европейским кардиологическим обществом, Американской коллегией кардиологов и Американской ассоциацией сердца (AKK/AAC). В статье изложены основные положения этого документа.
Full Text
##article.viewOnOriginalSite##References
- The Task Force on Beta-Blockers of the European Society of Cardiology. Expert consensus document onb - adrenergic receptor blockers. Eur Heart J 2004; 25: 1341–62.
- COMMIT/CCS-2 shows early hazard from IV b - blockade in higher - risk acute-MI patients. Сообщение подготовил Stiles S. www.theHeart.org.
- www.commit-ccs2.org
- Flather M.D, Shibata M.C, Coats A.J.S et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215–25.
- Willenheimer R, van Veldhuisen D.J, Silke B et al.Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril, as Compared With the Opposite Sequence Results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 2005; 112: 2426–35.
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the anagement of Patients With Acute Myocardial Infarction). Circulation 2004; 110: 588–636 (полный текст доступен на www.acc.org).
- The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology. Guidelines for the diagnosis and treatment of Chronic Heart Failure (update 2005). Eur Heart J 2005; 26: 1115–1140 (полный текст доступен на www.escardio.org).
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005; 112 (полный текст доступен на www.acc.org).
- The Task Force on Acute Heart Failure of the European Society of Cardiology. Guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005; 26: 384–416 (полный текст доступен на www.escardio.org).
- Carlberg B, Samuelsson O, Lindholm L.H. Atenolol in hypertension: is it a wise choice? Lancet 2004; 364: 1684–9.
- Lindholm L.H, Carlberg B, Samuelsson O. Should b blockers remain first choice in the treatment of primary hypertension? A meta - analysis. Lancet 2005; 366: 1545–53.
- The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003; 24: 28–66.
- CC/AHA/AHRQ/CMS/JCAHO Practice Advisory. Commitment to Respond to COMMIT/CCS-2 Trial Results. www.acc.org
- Dahlоf B, Sever P.S, Poulter N.R et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366: 895–906.
- Beevers D.G. The end of b blockers for uncomplicated hypertension? Lancet 2005; 366: 1510–2.
